What is Milestone Scient's earnings per share (EPS)?

Milestone Scient (MLSS) reported diluted earnings per share of $-0.07 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Milestone Scient Financials

MLSS

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE March

This page shows Milestone Scient (MLSS) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Earnings Quality Low Quality

0.51x

For every $1 of reported earnings, Milestone Scient generates $0.51 in operating cash flow (-$2.9M OCF vs -$5.7M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk

-195.1x

Milestone Scient earns $-195.1 in operating income for every $1 of interest expense (-$5.7M vs $29K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$9.0M

YoY+4.0%

5Y CAGR+10.5%

10Y CAGR-0.6%

Milestone Scient generated $9.0M in revenue in fiscal year 2025. This represents an increase of 4.0% from the prior year.

EBITDA

-$5.6M

YoY+16.4%

Milestone Scient's EBITDA was -$5.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 16.4% from the prior year.

Net Income

-$5.7M

YoY-21.4%

Milestone Scient reported -$5.7M in net income in fiscal year 2025. This represents a decrease of 21.4% from the prior year.

EPS (Diluted)

$-0.07

Milestone Scient earned $-0.07 per diluted share (EPS) in fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow

-$2.9M

Milestone Scient generated -$2.9M in free cash flow in fiscal year 2025, representing cash available after capex.

Cash & Debt

N/A

Dividends Per Share

N/A

Shares Outstanding

80M

YoY+3.1%

5Y CAGR+4.8%

10Y CAGR+14.0%

Milestone Scient had 80M shares outstanding in fiscal year 2025. This represents an increase of 3.1% from the prior year.

Margins & Returns

Gross Margin

71.4%

YoY-3.2pp

5Y CAGR+4.8pp

10Y CAGR+3.5pp

Milestone Scient's gross margin was 71.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 3.2 percentage points from the prior year.

Operating Margin

-63.5%

YoY+14.8pp

5Y CAGR+73.6pp

10Y CAGR-31.3pp

Milestone Scient's operating margin was -63.5% in fiscal year 2025, reflecting core business profitability. This is up 14.8 percentage points from the prior year.

Net Margin

-63.8%

YoY-9.1pp

5Y CAGR+71.2pp

10Y CAGR-6.2pp

Milestone Scient's net profit margin was -63.8% in fiscal year 2025, showing the share of revenue converted to profit. This is down 9.1 percentage points from the prior year.

Return on Equity

N/A

Capital Allocation

R&D Spending

$449K

YoY-47.7%

5Y CAGR+7.9%

10Y CAGR+16.1%

Milestone Scient invested $449K in research and development in fiscal year 2025. This represents a decrease of 47.7% from the prior year.

Share Buybacks

N/A

Capital Expenditures

$15K

5Y CAGR-6.7%

10Y CAGR-13.9%

Milestone Scient invested $15K in capex in fiscal year 2025, funding long-term assets and infrastructure.

MLSS Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$9.0M+4.0%	$8.6M-12.2%	$9.8M+11.6%	$8.8M-14.5%	$10.3M+89.5%	$5.4M
Cost of Revenue	$2.6M+16.9%	$2.2M-27.7%	$3.0M-22.3%	$3.9M-2.2%	$4.0M+119.9%	$1.8M
Gross Profit	$6.4M-0.4%	$6.4M-5.3%	$6.8M+38.6%	$4.9M-22.4%	$6.3M+74.3%	$3.6M
R&D Expenses	$449K-47.7%	$859K+22.4%	$701K-39.0%	$1.2M+31.0%	$878K+185.3%	$308K
SG&A Expenses	$11.6M-5.8%	$12.3M-6.4%	$13.1M+5.0%	$12.5M-1.8%	$12.7M+19.4%	$10.7M
Operating Income	-$5.7M+15.7%	-$6.8M+4.9%	-$7.1M+19.5%	-$8.8M-19.6%	-$7.4M+1.0%	-$7.5M
Interest Expense	$29K-51.5%	$60K-52.0%	$126K+129.9%	$55K+433.8%	-$16K+9.5%	-$18K
Income Tax	N/A	N/A	$0	$0-100.0%	$333-97.9%	$16K
Net Income	-$5.7M-21.4%	-$4.7M+32.0%	-$6.9M+20.4%	-$8.7M-27.7%	-$6.8M+7.1%	-$7.3M
EPS (Diluted)	$-0.07	N/A	N/A	N/A	$-0.10+16.7%	$-0.12

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	$2.4M+1.6%	$2.3M+4.1%	$2.2M+10.9%	$2.0M-19.9%	$2.5M+35.6%	$1.9M-17.6%	$2.2M-0.5%	$2.3M
Cost of Revenue	$719K+1.9%	$706K+20.7%	$585K+16.4%	$502K-25.8%	$678K+53.1%	$443K-22.7%	$573K-23.7%	$751K
Gross Profit	$1.6M+1.4%	$1.6M-1.8%	$1.6M+9.0%	$1.5M-17.7%	$1.8M+30.1%	$1.4M-15.8%	$1.7M+11.0%	$1.5M
R&D Expenses	$16K-68.7%	$52K-86.0%	$369K+69.7%	$218K-6.3%	$232K-26.3%	$315K+234.3%	$94K-46.7%	$177K
SG&A Expenses	$2.7M-9.6%	$3.0M-6.9%	$3.3M-2.1%	$3.3M+8.6%	$3.1M+6.9%	$2.9M-5.5%	$3.0M-8.0%	$3.3M
Operating Income	-$1.1M+23.6%	-$1.5M+25.7%	-$2.0M+2.2%	-$2.0M-39.0%	-$1.5M+17.5%	-$1.8M-21.5%	-$1.5M+26.0%	-$2.0M
Interest Expense	N/A	$2K-53.4%	$3K-51.6%	$7K-15.7%	$8K-61.8%	$21K-14.6%	$25K+7.3%	$23K
Income Tax	N/A	$0	N/A	N/A	N/A	$0	$0	N/A
Net Income	-$1.2M+22.2%	-$1.5M+25.6%	-$2.0M+2.0%	-$2.0M-39.3%	-$1.5M-753.4%	$224K+115.5%	-$1.4M+25.7%	-$1.9M
EPS (Diluted)	$-0.01	N/A	N/A	N/A	$-0.02	N/A	N/A	N/A

MLSS Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	N/A	$9.8M-13.8%	$11.4M-17.0%	$13.7M-30.8%	$19.8M+1.2%	$19.6M
Current Assets	N/A	$9.3M-14.0%	$10.8M-16.8%	$13.0M-31.5%	$18.9M+2.0%	$18.6M
Cash & Equivalents	N/A	$3.3M+9.4%	$3.0M-65.8%	$8.7M-41.0%	$14.8M+3.8%	$14.2M
Inventory	N/A	$3.7M+40.7%	$2.6M+47.2%	$1.8M+16.3%	$1.5M-36.3%	$2.4M
Accounts Receivable	N/A	$475K+52.0%	$313K-54.9%	$694K-26.5%	$943K-12.7%	$1.1M
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	N/A	$4.0M+18.0%	$3.4M-9.1%	$3.7M+2.8%	$3.6M+3.7%	$3.5M
Current Liabilities	N/A	$3.7M+21.7%	$3.1M-6.8%	$3.3M+6.5%	$3.1M+7.6%	$2.9M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	N/A	$5.8M-27.2%	$8.0M-21.6%	$10.2M-37.5%	$16.4M+1.0%	$16.2M
Retained Earnings	N/A	-$128.1M-3.8%	-$123.3M-6.0%	-$116.4M-8.1%	-$107.7M-6.8%	-$100.9M

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$8.5M+5.4%	$8.1M-11.4%	$9.1M-7.2%	$9.8M-12.3%	$11.2M-6.9%	$12.0M+5.8%	$11.4M-0.2%	$11.4M
Current Assets	$8.1M+6.3%	$7.6M-11.5%	$8.6M-7.1%	$9.3M-13.2%	$10.7M-6.9%	$11.5M+6.3%	$10.8M+0.2%	$10.8M
Cash & Equivalents	$1.3M+5.6%	$1.3M-43.3%	$2.2M-31.1%	$3.3M-31.8%	$4.8M-17.0%	$5.8M+43.6%	$4.0M+34.5%	$3.0M
Inventory	$4.1M+5.9%	$3.9M-6.3%	$4.2M+12.0%	$3.7M0.0%	$3.7M+11.5%	$3.3M+16.4%	$2.9M+8.4%	$2.6M
Accounts Receivable	N/A	N/A	N/A	$475K-13.7%	$551K+42.4%	$387K-41.6%	$662K+111.7%	$313K
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$5.9M+26.0%	$4.7M+1.8%	$4.6M+16.7%	$4.0M+0.3%	$4.0M-2.4%	$4.1M+4.1%	$3.9M+15.8%	$3.4M
Current Liabilities	$5.0M+33.6%	$3.8M-15.2%	$4.4M+18.7%	$3.7M-0.4%	$3.8M-1.8%	$3.8M+5.2%	$3.6M+18.2%	$3.1M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$2.5M-23.7%	$3.3M-25.1%	$4.5M-23.5%	$5.8M-19.2%	$7.2M-9.2%	$8.0M+6.6%	$7.5M-6.9%	$8.0M
Retained Earnings	-$132.7M-0.9%	-$131.5M-1.1%	-$130.0M-1.6%	-$128.1M-1.6%	-$126.0M-1.2%	-$124.6M+0.2%	-$124.8M-1.2%	-$123.3M

MLSS Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$2.9M+0.1%	-$2.9M+45.2%	-$5.3M+11.7%	-$6.0M-49.5%	-$4.0M+42.3%	-$7.0M
Capital Expenditures	$15K	N/A	N/A	$9K-43.9%	$15K-29.1%	$21K
Free Cash Flow	-$2.9M	N/A	N/A	-$6.0M-49.2%	-$4.0M+42.2%	-$7.0M
Investing Cash Flow	-$15K-100.5%	$3.0M+199.8%	-$3.0M-34756.0%	-$9K+43.9%	-$15K+29.1%	-$21K
Financing Cash Flow	$786K+236.4%	$234K-90.9%	$2.6M+30071.1%	-$9K-100.2%	$4.6M-76.7%	$19.7M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	$82K+104.6%	-$1.8M-75.0%	-$1.0M+33.3%	-$1.5M-55.2%	-$974K-224.3%	$784K+164.3%	-$1.2M+2.2%	-$1.2M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$6K-39.4%	-$4K-242.9%	-$1K+63.0%	-$4K	$0-100.0%	$966K-51.8%	$2.0M+489.7%	-$514K
Financing Cash Flow	-$5K-100.6%	$797K+35068.5%	-$2K+9.7%	-$3K+2.8%	-$3K-2.2%	-$3K-101.1%	$241K-90.6%	$2.6M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

MLSS Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	71.4%-3.2pp	74.6%+5.4pp	69.1%+13.5pp	55.6%-5.6pp	61.3%-5.3pp	66.6%
Operating Margin	-63.5%+14.8pp	-78.3%-6.0pp	-72.3%+27.9pp	-100.2%-28.6pp	-71.6%+65.5pp	-137.1%
Net Margin	-63.8%-9.1pp	-54.6%+15.9pp	-70.5%+28.4pp	-98.9%-32.7pp	-66.2%+68.8pp	-134.9%
Return on Equity	N/A	-80.8%+5.7pp	-86.5%-1.3pp	-85.1%-43.5pp	-41.7%+3.6pp	-45.3%
Return on Assets	N/A	-48.1%+12.8pp	-60.9%+2.6pp	-63.5%-29.1pp	-34.4%+3.1pp	-37.5%
Current Ratio	N/A	2.48-1.0	3.51-0.4	3.93-2.2	6.11-0.3	6.45
Debt-to-Equity	N/A	0.68+0.3	0.42+0.1	0.36+0.1	0.220.0	0.21
FCF Margin	-32.7%	N/A	N/A	-68.6%-29.3pp	-39.3%+89.6pp	-128.9%

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Gross Margin	69.5%-0.1pp	69.6%-4.2pp	73.8%-1.2pp	75.0%+2.0pp	73.0%-3.1pp	76.1%+1.6pp	74.5%+7.8pp	66.8%
Operating Margin	-48.1%+15.8pp	-63.9%+25.6pp	-89.5%+11.9pp	-101.4%-43.0pp	-58.4%+37.6pp	-96.0%-30.9pp	-65.1%+22.4pp	-87.6%
Net Margin	-48.9%+14.9pp	-63.8%+25.5pp	-89.3%+11.7pp	-101.1%-43.0pp	-58.1%-70.2pp	12.1%+76.1pp	-64.1%+21.7pp	-85.8%
Return on Equity	-45.3%-0.9pp	-44.4%+0.3pp	-44.7%-9.8pp	-34.9%-14.7pp	-20.2%-23.0pp	2.8%+22.1pp	-19.3%+4.9pp	-24.2%
Return on Assets	-13.6%+4.8pp	-18.4%+3.5pp	-21.9%-1.2pp	-20.8%-7.7pp	-13.1%-14.9pp	1.9%+14.6pp	-12.7%+4.4pp	-17.1%
Current Ratio	1.61-0.4	2.03+0.1	1.94-0.5	2.48-0.4	2.85-0.2	3.00+0.0	2.97-0.5	3.51
Debt-to-Equity	2.33+0.9	1.41+0.4	1.04+0.4	0.68+0.1	0.55+0.0	0.51-0.0	0.52+0.1	0.42
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

Nephros Inc NEPH

$30.5M

Precision Optics POCI

$46.7M

Retractable Tech RVP

$20.6M

Harvard Biosci HBIO

$23.3M

Nexgel Inc NXGL

$4.8M

Frequently Asked Questions

What is Milestone Scient's annual revenue?

Milestone Scient (MLSS) reported $9.0M in total revenue for fiscal year 2025. This represents a 4.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Milestone Scient's revenue growing?

Milestone Scient (MLSS) revenue grew by 4% year-over-year, from $8.6M to $9.0M in fiscal year 2025.

Is Milestone Scient profitable?

No, Milestone Scient (MLSS) reported a net income of -$5.7M in fiscal year 2025, with a net profit margin of -63.8%.

What is Milestone Scient's EBITDA?

Milestone Scient (MLSS) had EBITDA of -$5.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Milestone Scient's gross margin?

Milestone Scient (MLSS) had a gross margin of 71.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Milestone Scient's operating margin?

Milestone Scient (MLSS) had an operating margin of -63.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Milestone Scient's net profit margin?

Milestone Scient (MLSS) had a net profit margin of -63.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Milestone Scient's free cash flow?

Milestone Scient (MLSS) generated -$2.9M in free cash flow during fiscal year 2025. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Milestone Scient's operating cash flow?

Milestone Scient (MLSS) generated -$2.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Milestone Scient's capital expenditures?

Milestone Scient (MLSS) invested $15K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Milestone Scient spend on research and development?

Milestone Scient (MLSS) invested $449K in research and development during fiscal year 2025.

How many shares does Milestone Scient have outstanding?

Milestone Scient (MLSS) had 80M shares outstanding as of fiscal year 2025.

Are Milestone Scient's earnings high quality?

Milestone Scient (MLSS) has an earnings quality ratio of 0.51x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Milestone Scient cover its interest payments?

Milestone Scient (MLSS) has an interest coverage ratio of -195.1x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.